You are required to be logged in to access the full website
User Name: Password:
Click here if you have forgotten your username or password
  • Home
  • Latest News
  • Search
  • About M2 Pharma
  • Subscribe
Business & Finance
Generics
Therapy Areas
Policy & Regulation
Research & Development
People
Business & Finance
Abbott announces quarterly common dividend increase
15 December 2025 -

Abbott (NYSE: ABT), a global healthcare company, on Friday announced its quarterly common dividend.

The company has declared a dividend of USD0.63 per share, up 6.8% compared to the year-ago period.

This dividend will be paid to shareholders of record at 15 January 2026 on 13 February 2026.

This marks Abbott's 54th consecutive year of dividend growth and is the 408th consecutive quarterly dividend to be paid by Abbott since 1924.

Login
Username:

Password:


Related Headlines

CVS Health announces quarterly dividend of USD0.665 per share

Convatec launches co-branded eakin freeseal ostomy seal in North America

UHS to acquire Talkspace for USD835m

Abbott announces quarterly dividend

Aptamer Optimer technology integrated into Twist Bioscience TrueAmp Library Preparation Kit

Alvotech reports positive PK study results for AVT80 biosimilar candidate

Inspiration Healthcare secures US purchasing agreement to drive Airon growth

West to sell SmartDose 3.5mL On-Body Delivery System rights to AbbVie for USD112.5m

Citius Pharmaceuticals reports full-year financial results

Sanofi receives FDA complete response letter for tolebrutinib in progressive MS

Abbott announces quarterly common dividend increase

Amgen announces Q1 2026 dividend

Eli Lilly announces Q1 2026 dividend

Oxford Nanopore and bioMérieux introduce AmPORE-TB for rapid tuberculosis resistance characterisation

Amgen announces Q4 2025 dividend

Home | Business & Finance | Generics | Therapy Areas | Policy & Regulation | Research & Development | People | Search | About M2 Pharma | Subscribe
Copyright © 2026